Park Il-Jung, Kim Hyoung-Min, Lee Jae-Young, Roh Youn-Tae, Kim Do-Yeol, Jeon Neung-Han, Kim Yong-Deok, Kang Soo-Hwan
Department of Orthopaedic Surgery, College of Medicine, Bucheon St. Mary's Hospital, The Catholic University of Korea, Republic of Korea.
Department of Orthopaedic Surgery, Good Samsun Hospital, 326 Gaya-daero, Sasang-gu, Busan 47007, Republic of Korea.
J Plast Reconstr Aesthet Surg. 2016 Oct;69(10):1403-10. doi: 10.1016/j.bjps.2016.07.013. Epub 2016 Jul 21.
Vascularized bone grafts for the treatment of Kienböck's disease may facilitate revascularization and remodeling of the avascular lunate. The aim of this study was to evaluate the radiological and clinical results obtained when a fourth extensor compartmental artery (ECA) bone graft was used to treat Kienböck's disease.
Between May 2009 and June 2012, 13 patients (6 men, 7 women) with Kienböck's disease were treated with placement of fourth ECA vascularized bone grafts. The mean patient age was 39.2 (20-58) years, and the mean follow-up period was 32.5 (12-72) months. At the time of surgery, One patient had Lichtman's stage II Kienböck's disease, 11 stage IIIA disease, and one stage IIIB disease. We measured the pre- and post-operative ranges of motion, pain, grip strength, and radiological parameters, including the carpal height ratio and the radioscaphoid angle.
At the last follow-up, pain was significantly reduced, and grip strength had improved from 60.5% to 87.8% relative to that of the contralateral side. The mean range of motion for flexion had improved from 39° to 53° while that of wrist joint extension improved from 41° to 56°. There were little or no changes in either the carpal height ratio or the radioscaphoid angle (both p values > 0.05).
Placing of a fourth ECA vascularized bone graft is a reliable alternative to other revascularization procedures for treatment of Kienböck's disease. Such grafting is effective, minimally invasive, and associated with a low risk of pedicle kinking.
TYPE OF STUDY/LEVEL OF EVIDENCE: Therapeutic/IV.
用于治疗月骨无菌性坏死的带血管骨移植可能有助于无血管的月骨的血管再生和重塑。本研究的目的是评估使用第四伸肌间隔动脉(ECA)骨移植治疗月骨无菌性坏死的放射学和临床结果。
2009年5月至2012年6月期间,13例(6例男性,7例女性)月骨无菌性坏死患者接受了第四ECA带血管骨移植术。患者平均年龄为39.2岁(20 - 58岁),平均随访期为32.5个月(12 - 72个月)。手术时,1例患者为Lichtman II期月骨无菌性坏死,11例为IIIA期,1例为IIIB期。我们测量了术前和术后的活动范围、疼痛、握力以及放射学参数,包括腕高比和桡舟角。
在最后一次随访时,疼痛明显减轻,握力相对于对侧从60.5%提高到了87.8%。平均屈曲活动范围从39°提高到了53°,而腕关节伸展活动范围从41°提高到了56°。腕高比和桡舟角几乎没有变化(p值均>0.05)。
植入第四ECA带血管骨移植是治疗月骨无菌性坏死的其他血管再生手术的可靠替代方法。这种移植有效、微创,且蒂部扭结风险低。
研究类型/证据水平:治疗性/IV级。